Unity Biotechnology Stock (NASDAQ: UBX) stock price, news, charts, stock research, profile.
Open | $1.34 |
Close | - |
Volume / Avg. | 60.12K / 59.91K |
Day Range | 1.33 - 1.43 |
52 Wk Range | 1.22 - 3.25 |
Market Cap | $22.50M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 1.94% |
Days to Cover | 4.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Unity Biotechnology (NASDAQ:UBX) through any online brokerage.
Other companies in Unity Biotechnology’s space includes: Vincerx Pharma (NASDAQ:VINC), Gain Therapeutics (NASDAQ:GANX), Nanoviricides (AMEX:NNVC), Bolt Biotherapeutics (NASDAQ:BOLT) and Longeveron (NASDAQ:LGVN).
There is no analysis for Unity Biotechnology.
Unity Biotechnology has a consensus price target of $6.38.
The stock price for Unity Biotechnology (NASDAQ: UBX) is $1.34 last updated July 8, 2024 at 5:06 PM EDT.
There are no upcoming dividends for Unity Biotechnology.
Unity Biotechnology’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Unity Biotechnology.
Unity Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.